Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Interferon gamma positive CD4-positive T cell" refers to a functional subset of CD4-positive T cells—commonly known as Th1 cells—that produce the cytokine interferon gamma (IFN‑γ). These cells play an essential role in orchestrating immune responses against intracellular pathogens such as viruses and certain bacteria by activating macrophages and promoting cellular immunity. The presence of these cells is often used as an indicator of Th1-type immune responses and can be measured using intracellular cytokine staining techniques in research and clinical immunology. While they are critical for host defense, dysregulation or overactivity of these cells is implicated in autoimmune diseases due to excessive inflammation[2][3][5]. Note on correctness: This entry does not correspond to a single molecule or canonical therapeutic target but rather describes a functional phenotype within the broader population of CD4-positive T helper lymphocytes. Therefore, it is not considered a standard druggable "target" like receptors or enzymes but rather an important biomarker or readout for immune function studies[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD4-positive T cell (interferon gamma positive).